CN105213557A - A kind of Chinese medicine composition for the treatment of eczema - Google Patents

A kind of Chinese medicine composition for the treatment of eczema Download PDF

Info

Publication number
CN105213557A
CN105213557A CN201510646496.4A CN201510646496A CN105213557A CN 105213557 A CN105213557 A CN 105213557A CN 201510646496 A CN201510646496 A CN 201510646496A CN 105213557 A CN105213557 A CN 105213557A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
radix
eczema
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201510646496.4A
Other languages
Chinese (zh)
Inventor
罗奕珺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510646496.4A priority Critical patent/CN105213557A/en
Publication of CN105213557A publication Critical patent/CN105213557A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the field of Chinese medicines, relate to a kind of Chinese medicine composition for the treatment of eczema.This Chinese medicine composition forms primarily of the raw materials of following parts by weight: Folium Artemisiae Argyi 26-35 part, Herba Portulacae 24-33 part, Herba Schizonepetae 19-24 part, Cortex Dictamni 20-27 part, Periostracum Cicadae 18-26 part, Rhizoma Coptidis 17-25 part, Radix Arnebiae (Radix Lithospermi) 19-26 part, Radix Astragali 14-20 part, Cortex cinnamomi japonici (Ramulus Cinnamomi) 13-20 part, Flos Albiziae 16-21 part, Caulis Polygoni Multiflori 15-22 part, leaf of Moringa 12-18 part, Folium Ginkgo 13-19 part and Radix Glycyrrhizae 10-20 part.This Chinese medicine composition has antipruritic instant effect in treatment eczema, and therapeutic effect is good, the advantage non-stimulated to skin, and its preparation process is simple and easy to do, preparation efficacy stability, and patient medication compliance is high, applied widely and be easy to apply.

Description

A kind of Chinese medicine composition for the treatment of eczema
Technical field
The invention belongs to the field of Chinese medicines, particularly relate to a kind of Chinese medicine composition for the treatment of eczema.
Background technology
Eczema is a kind of common allergic inflammation dermatoses, and its feature is pleomorphism erythra, oozes out tendency, symmetrical, is easy to recurrence and chronicity.More eczematosis, because of more complicated, thought anaphylactic disease at present, is belonged to type Ⅳ allergy.Anaphylactogen can from the external world, also can from internal body.Enviromental allergen as the toxin of chemical drugs, cosmetics, dyestuff, some animal, foreign preteins and some pollen, the dust etc. such as egg, fish, shrimp, milk.Inner anaphylactogen is as internal lesions, and intestinal parasitic disease, some metabolism, endocrine or digestive tract function imbalance and human body itself are under some is organized in the impact of some factor, and its composition changes and forms autoantibody etc.
The traditional Chinese medical science thinks that this disease is strong mainly due to disease just taste mistake, endogenous dampness, strongly fragrant heat-transformation of a specified duration, retention of damp-heat in the interior, and then rash color is scarlet for outer more skin, contamination flow liquid, and disease is recurrent exerbation for a long time, and cloudy blood is consumed; Qi-blood disharmony, the raw wind of dryness-transformation, failure of skin and muscle to be nourished, coarse plumpness, touching difficulty more.In a word, this disease belongs to damp and hot, and heat in blood, dampness, caused by blood is dry.Clinical should according to the body constitution of patient, arteries and veins card, Selection drug, can not adhere rigidly to into side.
Western medical treatment is based on antihistamine drug for oral administration, medicine for external use is mainly selected the soaks such as solution, lotion, paste or ointment according to different stadium performance or is coated with outward, when there is secondary infection, can consider to use antibiotic therapy, but there is larger toxic and side effects to skin in some Western medicine, the simultaneously treatment such as antibiotic, hormone not only directly can affect the health of patient, and long period or short-term heavy dose use, and addiction also can cause drug dependence dermatitis.
Folium Artemisiae Argyi is the dried leaves of feverfew Chinese mugwort, has another name called moxibustion grass, Artemisia argyi Levl. et Van. var. argyi cv. Qiai, Radix Artemisia ordosicae and Ai Peng etc., its bitter in the mouth, pungent, warm in nature; Return liver,spleen,kidney warp; Having blood of regulating the flow of vital energy, warming the meridian for stopping bleeding, the effects such as dispersing cold for relieving pain, is a kind of gynecological good medicine, and for spitting blood, epistaxis, metrorrhagia, menorrhagia, vaginal bleeding during pregnancy hematochezia, few abdomen cold type of pain, coldness and unbalance in meridians, cold womb is infertile.Pharmacological research represents, Folium Artemisiae Argyi all has antibacterial action to various bacteria such as staphylococcus aureus, escherichia coli, bacillus subtilis in vitro, and Oleum Folium Artemisiae Argyi has antagonism to the anaphylactic shock guinea-pigs that ovalbumin causes simultaneously, can reduce mortality rate.Chinese patent application 201210287998.9 discloses a kind of application compress for the treatment of eczema, this medicine is by being immersed in the rice vinegar through boiling cooling respectively by Rhizoma Smilacis Glabrae, Fructus Forsythiae, Herba Schizonepetae, Folium Artemisiae Argyi, Mirabilitum, Herba speranskiae tuberculatae, Radix Glycyrrhizae, Pericarpium Zanthoxyli Chinese crude drug, inoculate acetobacter, when different fermentations after indirect fermentation, then its fermentation liquid is blent make.This medicine has certain curative effect in treatment eczema, but this process for preparing medicine is complicated, and treatment is long for the course for the treatment of.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of Chinese medicine composition for the treatment of eczema, and this Chinese medicine composition can Quick itch stopping, and pointed strong, advantage that good effect, relapse rate are low, has good long-term effect.
In addition, the present invention also provides the preparation technology of this Chinese medicine composition, on the basis ensureing curative effect, Chinese medicine is made universality is strong, be easy to carry about with one the finished product preparation used.
The Chinese medicine composition for the treatment of eczema of the present invention forms primarily of the raw materials of following parts by weight: Folium Artemisiae Argyi 26-35 part, Herba Portulacae 24-33 part, Herba Schizonepetae 19-24 part, Cortex Dictamni 20-27 part, Periostracum Cicadae 18-26 part, Rhizoma Coptidis 17-25 part, Radix Arnebiae (Radix Lithospermi) 19-26 part, Radix Astragali 14-20 part, Cortex cinnamomi japonici (Ramulus Cinnamomi) 13-20 part, Flos Albiziae 16-21 part, Caulis Polygoni Multiflori 15-22 part, leaf of Moringa 12-18 part, Folium Ginkgo 13-19 part and Radix Glycyrrhizae 10-20 part.
Preferably, the Chinese medicine composition for the treatment of eczema of the present invention forms primarily of the raw materials of following parts by weight: Folium Artemisiae Argyi 26 parts, Herba Portulacae 24 parts, Herba Schizonepetae 19 parts, Cortex Dictamni 20 parts, Periostracum Cicadae 18 parts, Rhizoma Coptidis 17 parts, Radix Arnebiae (Radix Lithospermi) 19 parts, the Radix Astragali 14 parts, 13 parts, Cortex cinnamomi japonici (Ramulus Cinnamomi), Flos Albiziae 16 parts, Caulis Polygoni Multiflori 15 parts, leaf of Moringa 12 parts, Folium Ginkgo 13 parts and 10 parts, Radix Glycyrrhizae.
Preferably, the Chinese medicine composition for the treatment of eczema of the present invention forms primarily of the raw materials of following parts by weight: Folium Artemisiae Argyi 35 parts, Herba Portulacae 33 parts, Herba Schizonepetae 24 parts, Cortex Dictamni 27 parts, Periostracum Cicadae 26 parts, Rhizoma Coptidis 25 parts, Radix Arnebiae (Radix Lithospermi) 26 parts, the Radix Astragali 20 parts, 20 parts, Cortex cinnamomi japonici (Ramulus Cinnamomi), Flos Albiziae 21 parts, Caulis Polygoni Multiflori 22 parts, leaf of Moringa 18 parts, Folium Ginkgo 19 parts and 20 parts, Radix Glycyrrhizae.
Preferably, the Chinese medicine composition for the treatment of eczema of the present invention forms primarily of the raw materials of following parts by weight: Folium Artemisiae Argyi 30 parts, Herba Portulacae 30 parts, Herba Schizonepetae 22 parts, Cortex Dictamni 25 parts, Periostracum Cicadae 24 parts, Rhizoma Coptidis 23 parts, Radix Arnebiae (Radix Lithospermi) 23 parts, the Radix Astragali 18 parts, 17 parts, Cortex cinnamomi japonici (Ramulus Cinnamomi), Flos Albiziae 18 parts, Caulis Polygoni Multiflori 20 parts, leaf of Moringa 16 parts, Folium Ginkgo 15 parts and 15 parts, Radix Glycyrrhizae.
The preparation method of Chinese medicine composition of the present invention comprises following steps:
S1: get Herba Portulacae, wash away impurity, crushed after being dried, cross 60-80 mesh sieve, adding medical material gross weight 8-10 times amount volume fraction is the ethanol of 60-80%, microwave extraction 8-15 minute, microwave power is 240-300W, and Extracting temperature is 40-60 DEG C, filters and retains Herba Portulacae medicinal residues, the extractum that relative density is 1.20-1.25 is surveyed, obtained Herba portulacae extract at filtrate reduced in volume to 60 DEG C;
S2: get Folium Artemisiae Argyi, Herba Schizonepetae, Cortex Dictamni, Periostracum Cicadae, Rhizoma Coptidis, Radix Arnebiae (Radix Lithospermi), the Radix Astragali, Cortex cinnamomi japonici (Ramulus Cinnamomi), Flos Albiziae, Caulis Polygoni Multiflori, leaf of Moringa, Folium Ginkgo and Radix Glycyrrhizae, wash away impurity, crushed after being dried, merge described Herba Portulacae medicinal residues, add the water of coarse powder total amount 15-20 times amount, soak 20-30 minute, reflux, extract, 2-3 time, each 1-3 hour, filter, merging filtrate, the extractum that relative density is 1.10-1.20 is surveyed at filtrate reduced in volume to 60 DEG C, cooling, slowly add ethanol while stirring to alcohol content for reaching 40-60%, 4 DEG C of standing 12-24 hour, filter and retain filtering residue, obtain filtrate A,
S3: the filtering residue obtained in S2 slowly being added while stirring its weight 4-6 times amount volume fraction is the ethanol of 40-60%, 4 DEG C of standing 3-5 hour, filters, obtains liquor B and filtering residue; Filtering residue uses the washing with alcohol 2-3 time of 40-60% again, collects and merges cleaning mixture;
S4: merge described filtrate A, liquor B and cleaning mixture, surveys extractum that relative density be 1.20-1.25 under being evaporated to 60 DEG C of conditions after mixing;
S5: extractum obtained in described Herba portulacae extract and S4 is merged mixing, and carry out vacuum belt type drying at 60 DEG C of temperature, drying pressure is-0.08MPa, charging rate is 12L/h, and material strip transfer rate is 28cm/min, is pulverized by dry extract after drying, cross 100-200 mesh sieve, to obtain final product.
Utilize modern general Chinese medicine preparation technology, Chinese medicine composition of the present invention can be made into the finished product preparation of clinical needs, as dosage forms such as paste, gel, ointment, ointment or liniments.
Source, the nature and flavor of Chinese medicine composition of the present invention Chinese crude drug used, return through and effect:
Folium Artemisiae Argyi: this product is the dried leaves of feverfew Chinese mugwort; Acrid in the mouth, hardship, warm in nature; Return spleen, liver, kidney channel; To regulate the flow of vital energy blood, by cold-damp, dispersing cold for relieving pain, warming the meridian for stopping bleeding.
Herba Portulacae: this product is the dry herb of Portulacaceae annual herb plant; Acid, cold; Heat-clearing and toxic substances removing, loose blood detumescence.
Herba Schizonepetae: this product is the dry aerial parts of labiate Herba Schizonepetae; Acrid in the mouth, slightly warm in nature; Return lung, Liver Channel; Induce sweat loose wind, rash.
Cortex Dictamni: this product is the dry root bark of rutaceae shaggy-fruited dittany; Bitter in the mouth, cold in nature; Return spleen, stomach, urinary bladder channel; Heat clearing and damp drying, dispelling wind for relieving itching, removing toxic substances.
Periostracum Cicadae: exuviae shell when this product is the larva emergence of cicada Cryptotympana atrata Fabr.; Sweet in the mouth, cold in nature; Return lung, Liver Channel; Loose wind heat extraction, sore-throat relieving, rash, nebula removing, spasmolytic.
Rhizoma Coptidis: this product is the dry rhizome of ranunculaceae plant Rhizoma Coptidis, Coptis deltoidea C.Y.Cheng et Hsiao or Coptis Teeta Wall; Bitter in the mouth, cold in nature; GUIXIN, spleen, stomach, liver, gallbladder, large intestine channel; Heat clearing and damp drying, eliminating fire and detoxication.
Radix Arnebiae (Radix Lithospermi): this product is the dry root of comfrey lithospermum euchromum Royle, Radix Arnebiae (Radix Lithospermi) or arnebia guttata Bunge; Sweet in the mouth, salty, cold in nature; GUIXIN, Liver Channel; Removing heat from blood, invigorates blood circulation, removing toxic substances rash.
The Radix Astragali: this product is the root of leguminous plant Radix Hedysari multijugi; Sweet in the mouth, warm in nature; GUIXIN, lung, spleen, kidney channel; Invigorating QI to consolidate the body surface resistance, diuresis, expelling pus and toxin by strengthening QI, promoting tissue regeneration and ulcer healing.
Cortex cinnamomi japonici (Ramulus Cinnamomi): this product is the bark in canella Cinnamomum japonica, cloudy perfume, cinnamomum chingii Metcalf or osmanthus, river etc.; Acrid in the mouth, sweet, warm in nature; Return spleen, stomach, liver, kidney channel; Warming the spleen stomach, warm Liver and kidney, cold-dispelling pain-relieving, dissipating blood stasis for subsidence of swelling.
Flos Albiziae: this product is the dry inflorescence of leguminous plant Herba Albiziae; Sweet in the mouth, property is put down; GUIXIN, Liver Channel; Shu Yu, regulates the flow of vital energy, and calms the nerves, active.
Caulis Polygoni Multiflori: be rattan or the leaf bine stem of polygonum multiflorum thunb; Sweet in the mouth, micro-hardship, property is put down; GUIXIN, Liver Channel; Tranquilizing by nourishing the heart, dispels the wind, dredging collateral.
Leaf of Moringa: this product is the dry leaves of perennial tropical deciduous tree Moringa tree (being also called drumstick tree), has the effects such as blood sugar lowering, blood fat reducing, blood pressure lowering, antitumor, antioxidation, relieving constipation, diuresis, anthelmintic, improving water flood.
Folium Ginkgo: this product is the dried leaves of Ginkgoaceae plant Ginkgo biloba; Sweet, bitter, puckery, flat; GUIXIN, lung meridian; Blood circulation promoting and blood stasis dispelling, removing obstruction in the collateral to relieve pain, astringes the lung and relievings asthma, and changes turbid blood fat reducing.
Radix Glycyrrhizae: this product is the dry root of glycyrrhizic legume, Glycyrrhiza inflata Bat. or Glycyrrhiza glabra L..Sweet in the mouth, property is put down; GUIXIN, lung, spleen, stomach warp; Invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, coordinating the actions of various ingredients in a prescription.
The prescription analysis of Chinese prescription of the present invention:
Chinese medicine composition of the present invention is with Folium Artemisiae Argyi, Herba Schizonepetae, Herba Portulacae for monarch drug, warming middle-JIAO to relieve pain, detoxifying and relieving itching; With Cortex Dictamni, Periostracum Cicadae, Rhizoma Coptidis, Radix Arnebiae (Radix Lithospermi) for ministerial drug, removing toxic substances rash, heat clearing and damp drying, eliminating fire and detoxication; With Caulis Polygoni Multiflori, the Radix Astragali, Cortex cinnamomi japonici (Ramulus Cinnamomi), Flos Albiziae, leaf of Moringa, Folium Ginkgo for adjuvant drug, tranquilizing by nourishing the heart, expelling pus and toxin by strengthening QI; With Radix Glycyrrhizae for making medicine, invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, coordinating the actions of various ingredients in a prescription, makes all medicines arrange in pairs or groups, jointly reaches sterilizing and itch-relieving, and removing toxic substances rash, expelling pus and toxin by strengthening QI, effect of promoting tissue regeneration and ulcer healing, has significant therapeutic effect to eczema.
Through clinical trial checking, Chinese medicine composition of the present invention has following advantage compared with existing medicine:
1) the present invention significantly can improve the symptom of eczema, rapid-action, treatment short treating period, and can suppress secondary infection.
2) Chinese medicine composition of the present invention is natural pure Chinese medicinal preparation, and toxic and side effects is little, to no skin irritation.
3) Chinese medicine composition synergism of the present invention is strong, and using dosage is little, can not produce drug dependence simultaneously.
Detailed description of the invention
Further describe the present invention below by way of specific embodiment, the present invention is not limited only to following examples.Within the scope of the invention or not departing from content of the present invention, spirit and scope, the change carried out the present invention, combination or replacement, be apparent for a person skilled in the art, and be included within the scope of the present invention.
EXAMPLE l
The embodiment of the present invention 1 Chinese medicine composition forms primarily of the raw materials of following parts by weight:
Folium Artemisiae Argyi 26 parts, Herba Portulacae 24 parts, Herba Schizonepetae 19 parts, Cortex Dictamni 20 parts, Periostracum Cicadae 18 parts, Rhizoma Coptidis 17 parts, Radix Arnebiae (Radix Lithospermi) 19 parts, the Radix Astragali 14 parts, 13 parts, Cortex cinnamomi japonici (Ramulus Cinnamomi), Flos Albiziae 16 parts, Caulis Polygoni Multiflori 15 parts, leaf of Moringa 12 parts, Folium Ginkgo 13 parts and 10 parts, Radix Glycyrrhizae.
Preparation method:
S1: get Herba Portulacae, wash away impurity, crushed after being dried, cross 60 mesh sieves, adding medical material gross weight 10 times amount volume fraction is the ethanol of 60%, microwave extraction 8 minutes, microwave power is 240W, and Extracting temperature is 40 DEG C, filters and retains Herba Portulacae medicinal residues, the extractum that relative density is 1.20 is surveyed, obtained Herba portulacae extract at filtrate reduced in volume to 60 DEG C;
S2: get Folium Artemisiae Argyi, Herba Schizonepetae, Cortex Dictamni, Periostracum Cicadae, Rhizoma Coptidis, Radix Arnebiae (Radix Lithospermi), the Radix Astragali, Cortex cinnamomi japonici (Ramulus Cinnamomi), Flos Albiziae, Caulis Polygoni Multiflori, leaf of Moringa, Folium Ginkgo and Radix Glycyrrhizae, wash away impurity, crushed after being dried, merge described Herba Portulacae medicinal residues, add the water of coarse powder total amount 15 times amount, soak 30 minutes, reflux, extract, 2 times, each 3 hours, filter, merging filtrate, surveys the extractum that relative density is 1.10 at filtrate reduced in volume to 60 DEG C, cooling, slowly add ethanol while stirring to alcohol content for reaching 40%, 4 DEG C leave standstill 24 hours, filter and retain filtering residue, obtaining filtrate A;
S3: the filtering residue obtained in S2 slowly being added while stirring its weight 4 times amount volume fraction is the ethanol of 60%, 4 DEG C leave standstill 5 hours, filter, obtain liquor B and filtering residue; Filtering residue uses the washing with alcohol 3 times of 60% again, collects and merges cleaning mixture;
S4: merge described filtrate A, liquor B and cleaning mixture, surveys extractum that relative density be 1.20 under being evaporated to 60 DEG C of conditions after mixing;
S5: extractum obtained in described Herba portulacae extract and S4 is merged mixing, vacuum belt type drying is carried out at 60 DEG C of temperature, drying pressure is-0.08MPa, charging rate is 12L/h, material strip transfer rate is 28cm/min, after drying, dry extract is pulverized, cross 100 mesh sieves, obtain Chinese medicine composition fine powder of the present invention;
S6: carbomer and emulsifying agent Polysorbate are added enough water soakings 30 hours, makes carbomer moisten completely and rises, then adds sodium citrate and glacial acetic acid regulates its pH value to be 7.5, mix homogeneously, obtained gel-type vehicle;
S7: the Chinese medicine composition fine powder of the present invention that S5 is obtained is soluble in water, joins in gel-type vehicle successively, stir glycerol and butanediol, Chinese medicine composition fine powder solution of the present invention, obtain Chinese medicine composition gelata of the present invention.
Embodiment 2
The embodiment of the present invention 2 Chinese medicine composition forms primarily of the raw materials of following parts by weight:
Folium Artemisiae Argyi 35 parts, Herba Portulacae 33 parts, Herba Schizonepetae 24 parts, Cortex Dictamni 27 parts, Periostracum Cicadae 26 parts, Rhizoma Coptidis 25 parts, Radix Arnebiae (Radix Lithospermi) 26 parts, the Radix Astragali 20 parts, 20 parts, Cortex cinnamomi japonici (Ramulus Cinnamomi), Flos Albiziae 21 parts, Caulis Polygoni Multiflori 22 parts, leaf of Moringa 18 parts, Folium Ginkgo 19 parts and 20 parts, Radix Glycyrrhizae.
Preparation method:
S1: get Herba Portulacae, wash away impurity, crushed after being dried, cross 80 mesh sieves, adding medical material gross weight 8 times amount volume fraction is the ethanol of 80%, microwave extraction 15 minutes, microwave power is 300W, and Extracting temperature is 60 DEG C, filters and retains Herba Portulacae medicinal residues, the extractum that relative density is 1.25 is surveyed, obtained Herba portulacae extract at filtrate reduced in volume to 60 DEG C;
S2: get Folium Artemisiae Argyi, Herba Schizonepetae, Cortex Dictamni, Periostracum Cicadae, Rhizoma Coptidis, Radix Arnebiae (Radix Lithospermi), the Radix Astragali, Cortex cinnamomi japonici (Ramulus Cinnamomi), Flos Albiziae, Caulis Polygoni Multiflori, leaf of Moringa, Folium Ginkgo and Radix Glycyrrhizae, wash away impurity, crushed after being dried, merge described Herba Portulacae medicinal residues, add the water of coarse powder total amount 20 times amount, soak 20 minutes, reflux, extract, 3 times, each 1 hour, filter, merging filtrate, surveys the extractum that relative density is 1.20 at filtrate reduced in volume to 60 DEG C, cooling, slowly add ethanol while stirring to alcohol content for reaching 60%, 4 DEG C leave standstill 12 hours, filter and retain filtering residue, obtaining filtrate A;
S3: the filtering residue obtained in S2 slowly being added while stirring its weight 6 times amount volume fraction is the ethanol of 40%, 4 DEG C leave standstill 3 hours, filter, obtain liquor B and filtering residue; Filtering residue uses the washing with alcohol 2 times of 60% again, collects and merges cleaning mixture;
S4: merge described filtrate A, liquor B and cleaning mixture, surveys extractum that relative density be 1.25 under being evaporated to 60 DEG C of conditions after mixing;
S5: extractum obtained in described Herba portulacae extract and S4 is merged mixing, vacuum belt type drying is carried out at 60 DEG C of temperature, drying pressure is-0.08MPa, charging rate is 12L/h, material strip transfer rate is 28cm/min, after drying, dry extract is pulverized, cross 200 mesh sieves, obtain Chinese medicine composition fine powder of the present invention;
S6: get sodium carboxymethyl cellulose and be placed in mortar, adds glycerol and grinds well, and then grinds while add the alcoholic solution of ethyl hydroxybenzoate, grinds well after swelling, and the Chinese medicine composition fine powder gradation that S5 is obtained adds, and grinds well, obtains the ointment of Chinese medicine composition of the present invention.
Embodiment 3
The embodiment of the present invention 3 Chinese medicine composition comprises the raw materials of following parts by weight:
Folium Artemisiae Argyi 30 parts, Herba Portulacae 30 parts, Herba Schizonepetae 22 parts, Cortex Dictamni 25 parts, Periostracum Cicadae 24 parts, Rhizoma Coptidis 23 parts, Radix Arnebiae (Radix Lithospermi) 23 parts, the Radix Astragali 18 parts, 17 parts, Cortex cinnamomi japonici (Ramulus Cinnamomi), Flos Albiziae 18 parts, Caulis Polygoni Multiflori 20 parts, leaf of Moringa 16 parts, Folium Ginkgo 15 parts and 15 parts, Radix Glycyrrhizae.
Preparation method:
S1: get Herba Portulacae, wash away impurity, crushed after being dried, cross 80 mesh sieves, adding medical material gross weight 9 times amount volume fraction is the ethanol of 70%, microwave extraction 10 minutes, microwave power is 280W, and Extracting temperature is 50 DEG C, filters and retains Herba Portulacae medicinal residues, the extractum that relative density is 1.20 is surveyed, obtained Herba portulacae extract at filtrate reduced in volume to 60 DEG C;
S2: get Folium Artemisiae Argyi, Herba Schizonepetae, Cortex Dictamni, Periostracum Cicadae, Rhizoma Coptidis, Radix Arnebiae (Radix Lithospermi), the Radix Astragali, Cortex cinnamomi japonici (Ramulus Cinnamomi), Flos Albiziae, Caulis Polygoni Multiflori, leaf of Moringa, Folium Ginkgo and Radix Glycyrrhizae, wash away impurity, crushed after being dried, merge described Herba Portulacae medicinal residues, add the water of coarse powder total amount 18 times amount, soak 25 minutes, reflux, extract, 3 times, each 1 hour, filter, merging filtrate, surveys the extractum that relative density is 1.20 at filtrate reduced in volume to 60 DEG C, cooling, slowly add ethanol while stirring to alcohol content for reaching 50%, 4 DEG C leave standstill 24 hours, filter and retain filtering residue, obtaining filtrate A;
S3: the filtering residue obtained in S2 slowly being added while stirring its weight 5 times amount volume fraction is the ethanol of 50%, 4 DEG C leave standstill 4 hours, filter, obtain liquor B and filtering residue; Filtering residue uses the washing with alcohol 3 times of 50% again, collects and merges cleaning mixture;
S4: merge described filtrate A, liquor B and cleaning mixture, surveys extractum that relative density be 1.20 under being evaporated to 60 DEG C of conditions after mixing;
S5: extractum obtained in described Herba portulacae extract and S4 is merged mixing, vacuum belt type drying is carried out at 60 DEG C of temperature, drying pressure is-0.08MPa, charging rate is 12L/h, material strip transfer rate is 28cm/min, after drying, dry extract is pulverized, cross 200 mesh sieves, obtain Chinese medicine composition fine powder of the present invention;
S6: get sodium carboxymethyl cellulose and be placed in mortar, adds glycerol and grinds well, and then grinds while add the alcoholic solution of ethyl hydroxybenzoate, grinds well after swelling, and the Chinese medicine composition fine powder gradation that S5 is obtained adds, and grinds well, obtains the ointment of Chinese medicine composition of the present invention.
Chinese medicine composition pharmacodynamic study of the present invention:
Test one: Chinese medicine composition of the present invention is to the development test of ear eczema mice.
Experimental animal: provide cleaning grade kunming mice 50 by certain Bioisystech Co., Ltd, body weight 22g ± 4g, male and female half and half.50 mices are divided into 5 groups at random, often organize 10.
Ear eczema Establishment of mouse model: first day is in two-sided dinitrochlorobenzene (DNCB) the solution sensitization of smearing 40 μ L5% of mice ears, within 4th day, smear the DNCB solution of 40 μ L1%, once smeared once every four days afterwards, totally 5 times, set up ear eczema mouse model.
Dosage regimen:
A group: get the Chinese medicine composition gelata of the present invention that the embodiment of the present invention 1 is obtained; Smear DNCB excites rear 24h, 48h, 72h to be coated with trial drug outward inside mice ears at every turn, and 1g/ is each, 2 times/day.
B group: get the Chinese medicine composition ointment of the present invention that the embodiment of the present invention 2 is obtained; Dosage regimen is with A group.
C group: get the Chinese medicine composition ointment of the present invention that the embodiment of the present invention 3 is obtained; Dosage regimen is with A group.
Positive controls: get Compound Dexamethasone Cream (Baiyunshan Hejigong Medicine Factory of Guangzhou Baiyunshan Pharmaceutical Co., Ltd., the accurate word H44024298 of traditional Chinese medicines), dosage regimen is with A group.
Model control group: the gel getting not drug containing in the embodiment of the present invention 1, dosage regimen is with A group.
Carry out the score of skin lesion degree by following standard: the obvious redness of ears thickens and oozes out, or obviously keratinization incrustation person remembers 3 points; Mild redness, oozes out not obvious, or moderate keratinization person is designated as 2 points; Red and swollen and ooze out all not obvious person, or slight keratinization person is designated as 1 point; Normal skin is 0 point.
Use spiral micrometer to measure ear swelling thickness respectively simultaneously.
Table 1 Ge Zu ear skin lesion situation compares
Note: compare with model control group, *p0.05; *p0.01.
Drug test group is compared with model control group, and mouse ear skin lesion integration and ear swelling thickness all have significant difference.Test data shows, drug test group mice is compared with model control group mice, and ear's skin lesion is clearly better, and ear swelling degree obviously reduces, drug test group C group of the present invention simultaneously, the i.e. Chinese medicine composition of the present invention of the embodiment of the present invention 3 preparation and the therapeutic equivalence of positive controls.Result of the test shows, traditional Chinese medicine composition for treating of the present invention and prevention eczema successful, can be used for clinical expansion.
Test two: the clinical trial of Chinese medicine composition of the present invention.
One, diagnostic criteria
Draft with reference to the content of " diagnosis basis of eczema " in " Chinese medical disease Standardization of diagnosis and curative effect ".Diagnostic criteria is:
1, acute eczema
1) skin lesion is pleomorphism, as flushing, pimple, vesicle, erosion, ooze out, crust, desquamation, constant kind form exists simultaneously.
2) onset is anxious, conscious scorching hot, violent pruritus.
3) skin lesion is often symmetrical, common with places such as head, face, distal limbs, scrotum.Can general whole body.
4) subacute or chronic eczema can be developed into, time light time heavy, repeatedly do not heal.
2, subacute eczema: skin lesion oozes out less, based on pimple, papulovesicle, incrustation, squama.Have slight rotten to the corn face, color is more dark red.Also visible mild infiltration, violent pruritus.
3, chronic eczema: many limits office is in a certain position, and boundary is clear, have significantly plump infiltration, rough surface, or become in lichen sample, the brown red or brown of color, often with papulovesicle, crust, scratch.Be inclined to moistening change, normal recurrent exerbation, time light time heavy, have paroxysmal pruritus.
Two, clinical trial protocol
1. subjects basic document
The present invention collect clinical eczema volunteer 100 example, man 52 example, female 48 example, age 16-45 year, all experimenters are divided at random 2 groups, often organize 50,2 group case in sex, age, the course of disease etc. through statistical analysis, there is comparability.
2. trial drug and test method
Treatment group: ointment prepared by the embodiment of the present invention 3, often prop up ointment and contain medicine 12.5g, spread upon eczema place, every day, secondary, smeared 10 days continuously.
Positive controls: smear Compound Dexamethasone Cream (Baiyunshan Hejigong Medicine Factory of Guangzhou Baiyunshan Pharmaceutical Co., Ltd., the accurate word H44024298 of traditional Chinese medicines), twice daily, smear 10 days continuously.
3. criterion of therapeutical effect
Effective: eczema erythema obviously reduces, attack times reduces.
Invalid: compare with before treatment, symptom does not disappear or increases the weight of on the contrary.
Recurrence: cure latter 3 months and run into warm and still show effect.
4. therapeutic outcome, as shown in table 2
Table 2 therapeutic effect
Number of cases Effectively (example) Invalid (example) Recurrence (example) Total effective rate
Treatment group 50 47 3 1 94.0%
Positive controls 50 45 5 5 90.0%
Result of the test shows, the effect for the treatment of group traditional Chinese medicine composition for treating eczema of the present invention is better than positive control drug Compound Dexamethasone Cream.Treatment group is compared with positive controls, the total effective rate for the treatment of group is 94.0% higher than the total effective rate 90.0% of positive controls group, and the recurrence number of cases for the treatment of group is significantly lower than the recurrence number of cases of positive controls, clinical observation, treatment group patient has no any untoward reaction at therapeutic process.Traditional Chinese medicine composition for treating eczema of the present invention is rapid-action, and safety is high, and relapse rate is low, and clinical generalization value is high.

Claims (6)

1. treat a Chinese medicine composition for eczema, it is characterized in that, described Chinese medicine composition forms primarily of the raw materials of following weight portion:
Folium Artemisiae Argyi 26-35 part, Herba Portulacae 24-33 part, Herba Schizonepetae 19-24 part, Cortex Dictamni 20-27 part, Periostracum Cicadae 18-26 part, Rhizoma Coptidis 17-25 part, Radix Arnebiae (Radix Lithospermi) 19-26 part, Radix Astragali 14-20 part, Cortex cinnamomi japonici (Ramulus Cinnamomi) 13-20 part, Flos Albiziae 16-21 part, Caulis Polygoni Multiflori 15-22 part, leaf of Moringa 12-18 part, Folium Ginkgo 13-19 part and Radix Glycyrrhizae 10-20 part.
2. the Chinese medicine composition for the treatment of eczema according to claim 1, is characterized in that, described Chinese medicine composition forms primarily of the raw materials of following parts by weight:
Folium Artemisiae Argyi 26 parts, Herba Portulacae 24 parts, Herba Schizonepetae 19 parts, Cortex Dictamni 20 parts, Periostracum Cicadae 18 parts, Rhizoma Coptidis 17 parts, Radix Arnebiae (Radix Lithospermi) 19 parts, the Radix Astragali 14 parts, 13 parts, Cortex cinnamomi japonici (Ramulus Cinnamomi), Flos Albiziae 16 parts, Caulis Polygoni Multiflori 15 parts, leaf of Moringa 12 parts, Folium Ginkgo 13 parts and 10 parts, Radix Glycyrrhizae.
3. the Chinese medicine composition for the treatment of eczema according to claim 1, is characterized in that, described Chinese medicine composition forms primarily of the raw materials of following parts by weight:
Folium Artemisiae Argyi 35 parts, Herba Portulacae 33 parts, Herba Schizonepetae 24 parts, Cortex Dictamni 27 parts, Periostracum Cicadae 26 parts, Rhizoma Coptidis 25 parts, Radix Arnebiae (Radix Lithospermi) 26 parts, the Radix Astragali 20 parts, 20 parts, Cortex cinnamomi japonici (Ramulus Cinnamomi), Flos Albiziae 21 parts, Caulis Polygoni Multiflori 22 parts, leaf of Moringa 18 parts, Folium Ginkgo 19 parts and 20 parts, Radix Glycyrrhizae.
4. the Chinese medicine composition for the treatment of eczema according to claim 1, is characterized in that, described Chinese medicine composition forms primarily of the raw materials of following parts by weight:
Folium Artemisiae Argyi 30 parts, Herba Portulacae 30 parts, Herba Schizonepetae 22 parts, Cortex Dictamni 25 parts, Periostracum Cicadae 24 parts, Rhizoma Coptidis 23 parts, Radix Arnebiae (Radix Lithospermi) 23 parts, the Radix Astragali 18 parts, 17 parts, Cortex cinnamomi japonici (Ramulus Cinnamomi), Flos Albiziae 18 parts, Caulis Polygoni Multiflori 20 parts, leaf of Moringa 16 parts, Folium Ginkgo 15 parts and 15 parts, Radix Glycyrrhizae.
5., according to the Chinese medicine composition of the arbitrary described treatment eczema of claim 1-4, it is characterized in that, described Chinese medicine composition is made into paste, gel, ointment, ointment or liniment.
6., according to the preparation method of the Chinese medicine composition of the arbitrary described treatment eczema of claim 1-4, it is characterized in that, the preparation method of described Chinese medicine composition comprises following steps:
S1: get Herba Portulacae, wash away impurity, crushed after being dried, cross 60-80 mesh sieve, adding medical material gross weight 8-10 times amount volume fraction is the ethanol of 60-80%, microwave extraction 8-15 minute, microwave power is 240-300W, and Extracting temperature is 40-60 DEG C, filters and retains Herba Portulacae medicinal residues, the extractum that relative density is 1.20-1.25 is surveyed, obtained Herba portulacae extract at filtrate reduced in volume to 60 DEG C;
S2: get Folium Artemisiae Argyi, Herba Schizonepetae, Cortex Dictamni, Periostracum Cicadae, Rhizoma Coptidis, Radix Arnebiae (Radix Lithospermi), the Radix Astragali, Cortex cinnamomi japonici (Ramulus Cinnamomi), Flos Albiziae, Caulis Polygoni Multiflori, leaf of Moringa, Folium Ginkgo and Radix Glycyrrhizae, wash away impurity, crushed after being dried, merge described Herba Portulacae medicinal residues, add the water of coarse powder total amount 15-20 times amount, soak 20-30 minute, reflux, extract, 2-3 time, each 1-3 hour, filter, merging filtrate, the extractum that relative density is 1.10-1.20 is surveyed at filtrate reduced in volume to 60 DEG C, cooling, slowly add ethanol while stirring to alcohol content for reaching 40-60%, 4 DEG C of standing 12-24 hour, filter and retain filtering residue, obtain filtrate A,
S3: the filtering residue obtained in S2 slowly being added while stirring its weight 4-6 times amount volume fraction is the ethanol of 40-60%, 4 DEG C of standing 3-5 hour, filters, obtains liquor B and filtering residue; Filtering residue uses the washing with alcohol 2-3 time of 40-60% again, collects and merges cleaning mixture;
S4: merge described filtrate A, liquor B and cleaning mixture, surveys extractum that relative density be 1.20-1.25 under being evaporated to 60 DEG C of conditions after mixing;
S5: extractum obtained in described Herba portulacae extract and S4 is merged mixing, and carry out vacuum belt type drying at 60 DEG C of temperature, drying pressure is-0.08MPa, charging rate is 12L/h, and material strip transfer rate is 28cm/min, is pulverized by dry extract after drying, cross 100-200 mesh sieve, to obtain final product.
CN201510646496.4A 2015-09-30 2015-09-30 A kind of Chinese medicine composition for the treatment of eczema Withdrawn CN105213557A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510646496.4A CN105213557A (en) 2015-09-30 2015-09-30 A kind of Chinese medicine composition for the treatment of eczema

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510646496.4A CN105213557A (en) 2015-09-30 2015-09-30 A kind of Chinese medicine composition for the treatment of eczema

Publications (1)

Publication Number Publication Date
CN105213557A true CN105213557A (en) 2016-01-06

Family

ID=54983072

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510646496.4A Withdrawn CN105213557A (en) 2015-09-30 2015-09-30 A kind of Chinese medicine composition for the treatment of eczema

Country Status (1)

Country Link
CN (1) CN105213557A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105796807A (en) * 2016-04-29 2016-07-27 欧卉 Externally-applied medicine capable of treating acute eczema
CN105920093A (en) * 2016-06-24 2016-09-07 桂林淮安天然保健品开发有限公司 Medicinal composition for treating eczema
CN105998846A (en) * 2016-07-21 2016-10-12 何颖 Method for preparing product
CN116059300A (en) * 2022-11-29 2023-05-05 伊犁弥玥泉生物科技有限公司 Skin antibacterial paste and preparation process thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102861274A (en) * 2012-10-25 2013-01-09 辛晓林 External use traditional Chinese medicine for treating eczema
CN103202903A (en) * 2013-04-11 2013-07-17 徐樊 Traditional Chinese medicine preparation for treating skin eczema

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102861274A (en) * 2012-10-25 2013-01-09 辛晓林 External use traditional Chinese medicine for treating eczema
CN103202903A (en) * 2013-04-11 2013-07-17 徐樊 Traditional Chinese medicine preparation for treating skin eczema

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李德胜: "湿疹", 《广西中医药》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105796807A (en) * 2016-04-29 2016-07-27 欧卉 Externally-applied medicine capable of treating acute eczema
CN105920093A (en) * 2016-06-24 2016-09-07 桂林淮安天然保健品开发有限公司 Medicinal composition for treating eczema
CN105998846A (en) * 2016-07-21 2016-10-12 何颖 Method for preparing product
CN116059300A (en) * 2022-11-29 2023-05-05 伊犁弥玥泉生物科技有限公司 Skin antibacterial paste and preparation process thereof

Similar Documents

Publication Publication Date Title
CN103041173B (en) Traditional Chinese medicine external preparation for curing dermatitis and eczema and preparing method thereof
CN101518600B (en) Chinese medicinal composition for treating bacterial or fungal dermatosis and preparation method thereof
CN103520572A (en) Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition
CN102362950A (en) Traditional Chinese medicine for treating leucoderma
CN105213557A (en) A kind of Chinese medicine composition for the treatment of eczema
CN102178877B (en) External preparation for treating eczema of scrotum and preparation method thereof
CN110693977A (en) External traditional Chinese medicine for treating premature ejaculation and erectile dysfunction and preparation method thereof
CN105497261A (en) Matrix of patch for external use and patch and sleeping-aid patch made from matrix
CN101856475B (en) Chinese medicinal composition for treating gynecological inflammation and preparation method thereof
CN103055066A (en) Traditional Chinese medicine for improving sleep and preparation method thereof
CN105343847A (en) Traditional Chinese medicine composition for treating eczema containing folium artemisiae argyi and preparing method thereof
CN105213584A (en) A kind of Chinese medicine composition for the treatment of eczema and preparation method thereof
CN108721442B (en) Traditional Chinese medicine composition and preparation for treating burns, scalds and diaper dermatitis and preparation method thereof
CN103860977B (en) A kind of pharmaceutical composition for the treatment of dermatitis
CN103301373B (en) Pharmaceutical composition for treating postpartum perineal mucosal lesions
CN105213609A (en) A kind of Chinese medicine composition for the treatment of decubital ulcer and preparation method thereof
CN105169342A (en) Traditional Chinese medicine composition for treating eczema and preparation method thereof
CN104587034B (en) New application of a medicinal composition in treating oral ulcer
CN103585580A (en) Chinese medicinal preparation for treating recurrent oral ulceration
CN104523942B (en) One treats colpitic external preparation
CN112675264B (en) Composition for treating psoriasis, preparation method and application thereof
CN105287800A (en) Traditional Chinese medicine composition for treating eczema and preparing method thereof
CN115919964B (en) Pharmaceutical composition for treating cutaneous pruritus of hemodialysis patient and preparation method thereof
CN101940652A (en) Chinese medicinal liniment for treating psoriasis, multiple kinds of stubborn dermatitis and pruritus
CN105343496A (en) Traditional Chinese medicine composition for treating eczema and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20160106

WW01 Invention patent application withdrawn after publication